Mad Money Recap
Cramer's 'Mad Money' Recap: June 20
06/20/08 - 07:46 PM EDT
Click here for an archive of Cramer's "Mad Money" recaps.
"Today's selloff was led by all of the sectors we hate," Jim Cramer told viewers of his "Mad Money" TV show Friday. He told investors to stay away from the banks, retailers and automakers, which led today's decline. Instead, he told investors to stick with the theses he's been repeating over and over, mainly agriculture, mining, minerals, infrastructure and the petroleum complex focused on natural gas and oil infrastructure. Cramer recommended Gardner Denver (GDI - Cramer's Take - Stockpickr), a maker of the components needed to produce and ship oil where it's needed, as a new favorite in the oil patch. He last recommended the stock back on Sept. 26 at $36.60, and since then the stock is up 46%.
Cramer Interviews Medicis Pharmaceutical CEO |

Speculation Friday
For "Speculation Friday," Cramer featured Oil Sands Quest (BQI - Cramer's Take - Stockpickr) as a real estate play on the ever-increasing quest for more oil. Oil Sands Quest currently controls over 500,000 acres land in Saskatchewan, Canada -- perfect for oil sands drilling and could be sitting on up to 10 billion barrels of bitumen, or dirty oil. Cramer explained that while bitumen is harder to refine than light sweet crude, with oil well over $40 a barrel, the economics of oil sands now makes sense. But even if Oil Sands Quests doesn't find oil at all, Cramer values the company as a real estate play. Cramer compared Oil Sands Quest to Ivanhoe Energy (IVAN - Cramer's Take - Stockpickr), which recently purchased leases in Canada at a value of $2.8 million per square acre. Applying that number to Oil Sands' 1,200 square miles of land, Cramer said the company could be valued at $3.4 billion, or more than 3 times its current enterprise value. Cramer did caution viewers that Oil Sands Quest is speculative. The company has no revenue and has been issuing a slew of stock offerings which has been dilutive to its outstanding shares. He cautioned viewers that with Oil Sands Quest trading at just over $6, they must use caution when buying the speculative name and not pay up for the shares.Next Week's Gameplan
Cramer said he expects next week to be quiet with the beginning of the summer season upon us. So for next week's game plan, he recommended buying CVS Caremark (CVS - Cramer's Take - Stockpickr) after Walgreen (WAG - Cramer's Take - Stockpickr) reports what he expects to be a disappointing quarter. He also expects Rite-Aid (RAD - Cramer's Take - Stockpickr) to be a withering entity in the drug store marketplace. On Tuesday, Cramer recommended buying Darden (DRI - Cramer's Take - Stockpickr) before it reports on Tuesday. He said while everyone expects a weak quarter from Darden, he doesn't expect food costs to hurt the company as much as expected.
On Wednesday, Cramer recommended buying
Nike (NKE - Cramer's Take - Stockpickr) on any weakness ahead of the Olympics next quarter. "If you don't see any weakness, we take a pass," he noted. He also recommended buying
Research In Motion (RIMM - Cramer's Take - Stockpickr) ahead of what he expects to be an upside surprise.
Cramer said he's worried about Thursday, with
ConAgra (CAG - Cramer's Take - Stockpickr) reporting what's anticipated to be poor results. He said that
Discover Financial (DFS - Cramer's Take - Stockpickr),
home builder
Lennar (LEN - Cramer's Take - Stockpickr), and Rite-Aid also report, and he's not a fan of any of them. On the upside, Cramer mentioned only Accenture (ACN - Cramer's Take - Stockpickr) as a possible buy ahead of their earnings.
Medicis CEO Speaks
Cramer welcomed Jonah Shackman, chairman and CEO of Medicis Pharmaceutical (MRX - Cramer's Take - Stockpickr) to the show to discuss his company's latest products. Shackman explained that his company's LipoSonix product uses focused ultrasound waves to non-invasively bust up fat in the body so it can be removed naturally. The product has already been approved in Europe and elsewhere in the world, and Shackman expects approval in the U.S. by 2011. Medicis is currently conducting clinical trials on the procedure, and Shackman said he sees a clear path to approval by the FDA. He defended his company against criticism that its products will not receive the approvals it seeks. Cramer stopped short of recommending Medicis, but called the baseless criticisms of the company "short-minded."Lightning Round
In the Lightning Round, Cramer was bullish on John Deere (DE - Cramer's Take - Stockpickr), Williams (WMB - Cramer's Take - Stockpickr), Frontline (FRO - Cramer's Take - Stockpickr), Wal-Mart (WMT - Cramer's Take - Stockpickr), Costco (COST - Cramer's Take - Stockpickr), TJX (TJX - Cramer's Take - Stockpickr), Urban Outfitters (URBN - Cramer's Take - Stockpickr), Bucyrus International (BUCY - Cramer's Take - Stockpickr), Joy Global (JOYG - Cramer's Take - Stockpickr) and Southwestern Energy (SWN - Cramer's Take - Stockpickr). Cramer was bearish on Hologic (HOLX - Cramer's Take - Stockpickr), Navios Maritime (NM - Cramer's Take - Stockpickr), Manitowoc (MTW - Cramer's Take - Stockpickr) and MEMC Electronics (WFR - Cramer's Take - Stockpickr). Want more Cramer? Check out Jim's rules and commandments for investing by clicking here. For more of Cramer's insights during the Lightning Round, click here.Despite the political rhetoric, clean coal technology is years away, Cramer says.
Natural gas companies have benefitted the most from the hike in oil prices, Cramers says.
Cramer is bullish about Baldor Electric 's energy-efficient industrial motors.
These forgotten Internet stocks are being accumulated by hedge funds.
Raspberries for Apple; You'll be sorry, UBS; Fortress or Fort Knox? Wholly unappetizing Foods; give Liberty AOL or give them...
The GOP presidential candidate raised $27 million in July.
Some credit and debit cards give you some cash back on purchases. But you need to manage it well to benefit from it.
Sponsored by:



